Armstrong AW, Park SH, Patel V, Hogan M, Wang W-J, Davidson D, Chirikov V. Matching-adjusted indirect comparison (MAIC) of deucravacitinib versus adalimumab for the treatment of patients with moderate to severe plaque psoriasis over 2 years. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s112. Available from: https://jofskin.org/index.php/skin/article/view/1995